Pyogenic Granuloma Stimulates Angiogenesis in the Chick Embryo Chorioallantoic Membrane

International Journal of Microcirculation-Clinical and Experimental

Volumn 16, Issue 2, 1996, Pages 82-88

  Ribatti, Domenico ^a   Vacca, A ^b   Schiraldi, G ^c   Sorino, S ^a   Caprio, F ^c   Mazzotta, F ^c   Roncali, L ^a   Bonifazi, E ^c  

^a Institute of Human Anatomy   (Italy)

^b Department of Biomedical Sciences and Human Oncology ^*  (Italy)

^c UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

Author keywords

Angiogenesis; Angioma; Chorioallantoic membrane; Mast cells; Vasoproliferative processes

Indexed keywords

ADOLESCENT; ANIMAL; ARTICLE; BIOPSY; CASE CONTROL STUDY; CELL COUNT; CHICK EMBRYO; CHILD; CHORION; FEMALE; FETUS MEMBRANE; HUMAN; MALE; MAST CELL; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PATHOPHYSIOLOGY; PRESCHOOL CHILD; PYOGENIC GRANULOMA; SKIN DISEASE; VASCULARIZATION;

ADOLESCENT; ALLANTOIS; ANIMALS; BIOPSY; CASE-CONTROL STUDIES; CELL COUNT; CHICK EMBRYO; CHILD; CHILD, PRESCHOOL; CHORION; FEMALE; GRANULOMA, PYOGENIC; HUMANS; MALE; MAST CELLS; NEOVASCULARIZATION, PATHOLOGIC; SKIN DISEASES;

EID: 0030096699     PISSN: 01676865     EISSN: None     Source Type: Journal    
DOI: 10.1159/000179154     Document Type: Article

References (54)

1. Cullino PM: Angiogenesis factors; in Bascrga R (cd): Handbook of Experimental Pharmacology. Berlin. Springer. 1981. pp 427-449.
2. Folkman J: Angiogenesis: Initiation and control. Ann NY Acad Sei 1982:401:212-227.
3. Ribatti D, Vacca A, Roncali L, Dammacco F: Angiogenesis under normal and pathological conditions. I laematologica 1991:76:311-320.
4. Monlesano R: Regulation of angiogenesis in vitro. Eur J Clin Invest 1992:22:504-515.
5. Folkman J. Klagsbrun M: Angiogenic factors. Science 1987;235:442-447.
6. Klagsbrun M. D’Amore PA: Regulators of angiogenesis. Annu Rev Physiol 1991:53:217-239.
7. Auerbach W. Auerbach R: Angiogenesis inhibition: A review. Pharmacol Thcr 1994:63:265-311.
8. Reynolds LP, Killilea SD, Redmcr DA: Angiogenesis in the female reproductive system. FASEBJ 1992:6:886-892.
9. Folkman J. Brem H: Angiogenesis and inflammation; in Galliti JI. Goldtsein M. Snyderman R (eds): Inflammation: Basic Principles and Clinical Applications. New York. Raven Press. 1992. pp 821-839.
10. Folkman J: What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990:46:113-117.
11. Folkman J: Angiogenesis in psoriasis: Therapeutic implications. J Invest Dermatol 1972; 59:40-43.
12. Malhatra R, Stenn KS, Frenandez LA, Bravcr-man IM: Angiogenic properties of normal and psoriatic skin associate with epidermis, not dermis. Lab Invest 1989:61:162-165.
13. Furusato M. Fukunaga M. Kikuchi Y. Chiba S. Yorota K. Joh K. Aiawa S, Ishikawa E: Two and three-dimensional ultrastructura1 observations of angiogenesis in juvenile hemangioma. Virchows Arch (Cell Pathol) 1984:46:229-237.
14. Zaki Salahudoin S, Nakamura S, Biberfcld P, Kaplan MH, Markham PD, Larsson L, Gallo RC: Angiogenic properties of Kaposi's sarcoma-derived cells after long-term culture in vitro. Science 1988:242:430-433.
15. Ensoli B, Gendelman R, Markham P, Eiorelli V, Colombini S, Raflcld M, Cafaro A, Chang HK, Brady JN, Gallo RC: Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma. Nature 1994:371:674-680.
16. Vacca A. Ribatti D. Roncali L. Lospalluti M. Serio G. Carrel S. Dammacco F: Melanocyte tumor progression is associated with changes in angiogcnesis and expression of the 67 kilodal-ton laminin receptor. Cancer 1993:72:455-461.
17. Graham CH. Rivers J. Kerbel RS. Stankiewicz KS. White WL: Extent of vascularization as a prognostic indicator in thin (10.76 mm) malignant melanomas. Am J Pathol 1994:145:510-514.
18. Auerbach R. Auerbach W. Polakowski I: Assays for angiogcnesis. Pharmacol Ther 1991: 51:1-11.
19. Norrby K. Wooley D: Role of mast cells in milogcnesis and angiogcnesis in normal tissue and tumour tissue. Adv Biosci 1993:89:71-116.
20. Olivo M, Bhardway R, Schulze-Osthoff K, Sorg C, Jürgen-Jacob H, Flamme I: A comparative study on the effects of tumor necrosis factor-u (TNF-n). human angiogenic factor (h-AF) and basic fibroblast growth factor (bFGF) on the chorioallantoic membrane of the chick embryo. Anat Rec 1992:234:105-115.
21. Elias H. Hyde DM: Stereological measurements of isotropic structures: in Elias H. Hyde DM (eds): A Guide to Practical Stereology. Basel. Karger. 1983. pp 25-44.
22. Encrback L: Mast cells in rat gastrointestinal mucosa. I. Effects of fixation. Acta Pathol Microbiol Scand 1966:66:293-302.
23. Enerback L: Mast cells in rat gastrointestinal mucosa. II. Dye binding and mctachromatic properties. Acta Pathol Microbiol Scand 1966: 66:303-313.
24. Enerback L: Mast cell heterogeneity: The evolution of the concept of specific mucosal mast cells: in Befus AD. Bienenstock J. Denburg JA (eds): Mast Cell Differentiation and Heterogeneity. New York, Raven Press. 1986. pp 1-26.
25. Ribatti D. Contino R. Quondamatteo F. Formica V. Tursi A: Mast cell populations in the chick embryo lung and their response to compounds 48/80 and dcxamcthasonc. Anat Em-bryol (Berl) 1992:186:241-244.
26. Furitsu T, Saito H, Dvorak AM, Scwartz LB, Irani AMA, Burdick JF, Ishizaka K, Ishizaka T: Development of human mast cells in vitro. Proc Natl Acad Sei USA 1989:86:10039-10043.
27. Galli SJ: New insights into ‘the riddle of mast cells': Microenvironmental regulation of mast cells development and phenotypic heterogeneity. Lab Invest 1990;62:5-33.
28. Crisp AJ. Chapman CM. Kirkham SE. Schiller AL. Krane SM: Articular mastocytosis in rheumatoid arthritis. Arthritis Rheum 1984:30: 130-137.
29. Ribatti D. Contino R. Tursi A: Do mast cells intervene in the vasoproliferative processes of the rheumatoid synovitis? J Submicrosc Cytol Pathol 1989:20:635-637.
30. Bravcrman IM. Sibley J: Role of the microcirculation in the treatment and pathogenesis of psoriasis. J Invest Dermatol 1982:78:12-17.
31. Glowaeki J. Mulliken JB: Mast cells in hemangiomas and vascular malformations. Pediatrics 1982:70:48-51.
32. Kessler DA. Langer RS. Plcss NA. Folkman J: Mast cells and tumor angiogcnesis. Int J Cancer 1976;18:703-709.
33. Thorton SC. Mueller SM. Levine EM: Human endothelial cells: Use of heparin in cloning and long term cultivation. Science 1983:222:623-625.
34. Alessandri G. Raju KS. Gullino PM: Characterization of a chcmoattractant for endothelium induced by angiogenic effectors. Cancer Res 1984:44:1579-1584.
35. Norrby K. Sorbo J: Heparin enhances angio-gencsis by a systemic mode of action. Int J Exp Pathol 1992;73:147-155.
36. Norrby K: Heparin and angiogcnesis: A low-molecular weight fraction inhibits and a high-molecular weight fraction stimulates angiogen-csis systematically. Haemostasis 1993:23(suppl 1): 144-149.
37. Jakobson AM. Hahnenberger R: Antiangiogen-ic effect of heparin and other sulphated glycos-aminoglycans in the chick embryo chorioallantoic membrane. Pharmacol Toxicol I99L.69: 122-126.
38. Wilks JW, Scott PS, Urla LK, Cocuzza JM: Inhibition of angiogcnesis with combination treatments of angiostatic steroids and suramin. lntJ Radiat Biol 1991:60:73-77.
39. Taylor S. Folkman J: Protamine is an inhibitor ofangiogenesis. Nature 1982:297:307-312.
40. Castellot JJ. Karnovsky MJ. Spicgelman BM: Differentiation-dependent stimulation of neovascularization and endothelial cell Chemotaxis by 3T3 adipocytes. Proc Natl Acad Sei USA 1982:79:5597-5601.
41. Ribatti D. Roncali L. Nico B. Bertossi M: Effects of exogenous heparin on the vasculo-genesis of the chorioallantoic membrane. Acta Anat 1987;130:257-263.
42. Norrby K. Sorbo J: Heparin enhances angiogcnesis by a systemic mode of action. Int J Exp Pathol 1992:73:147-155.
43. Sorbo J. Jukobsson A. Norrby K: Mast cell histamine is angiogenic through receptors for histamine I and histamine 2. Int J Exp Pathol 1994:75:43-50.
44. Norrby K: Evidence for a dual role of endogenous histamine in angiogcnesis. Int J Exp Pathol 1995:76:87-92.
45. Motro B, Itin A, Sachs L, Keshet E: Pattern of interleukin 6 gene expression in vivo suggests a role for this evtokine in angiogcnesis. Proc Nall Acad Sei USA 1990:87:4068-4072.
46. Bussolino F. Ziehe M. Wang JM. Alessi D. Morbidclli I. Cremona O. Bosia A. Marchisio PC. Mantovani A: In vitro and in vivo activation of endothelial cells by colony stimulating factors. J Clin Invest 1991:87:986-995.
47. Roberts AB. Sporn MB. Assoian RK. Smith JM. Roche NS. Wakefield LM. Heine UI. Liot-ta LA. Falanga V. Kehr JH. Fauci AS: Transforming growth factor type-beta: Rapid induction of fibrosis and angiogcnesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sei USA 1986:83:4167-4171.
48. Blotnick S. Pcoplce GE. Freeman MR. Eber-lein TJ. Klagsbrun M: T lymphocytes synthesize and export heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor, mitogens for vascular cells and fibroblasts: Differential production and release by CD4+ and CD81- cells. Proc Natl Acad Sei USA 1994:91:2890-2894.
49. Baird A. Bohlen P: Fibroblast growth factors; in Spron MC. Roberts AB (eds): Peptide Growth Factors. New York. Springer. 1990. pp 369-417.
50. Kon K, Fujiwara T: Transformation of fibroblasts into endothelial cells during angiogene-sis. Cell Tissue Res 1994:278:625-628.
51. Ribatti D. Urbinati C. Nico B. Rusnati M. Roncali L. Prcsta M: Endogenous basic fibroblast growth factor is implicated in the vascularization of the chick embryo chorioallantoic membrane. Dev Biol 1995;170:39-49.
52. Halaban R. I-angdon R. Birchall W. Cuono C. Baird A. Scott G. Moellmamm G. McGuire J: Basic fibroblast growth factor from human kératinocytes is a natural mitogen for melanocytes. J Cell Biol 1988:107:1611-1619.
53. Coffey RJ Jr., Derynck R, Wilcox JN, Bringman TS, Gonstin AS, Moses HI, Dittcl-kow MR: Production and autoinoculation of transforming growth factor-ß in human kératinocytes. Nature 1987;328:817-820.
54. Akhurst RJ. Fee F. Balmain A: Localized production of TGF-u mRNA in tumor promoter-stimulated mouse epidermis. Nature 1988:331: 363-365.